Connecting on Coronavirus
We provide you with a brief update on what we’ve been doing over the past few months to support you and to feed into public discussion around COVID-19.
We provide you with a brief update on what we’ve been doing over the past few months to support you and to feed into public discussion around COVID-19.
British Society for Immunology response to interim phase 3 results from the AstraZeneca/University of Oxford trial for the ChAdOx1 nCoV-19 vaccine against COVID-19.
Our Policy and Public Affairs Manager, Matthew Gibbard, reviews the current political situation around Brexit and reminds us of key moments and decisions in the UK’s negotiations with the European Union.
We discuss the findings of the BSI’s new report ‘The ageing immune system and COVID-19’ and explain its importance, both for the BSI’s mission and for optimising patient care, treatment and vaccine approaches.
We’re pleased to announce the winner of our 2020 Immunology Teaching Excellence Award, Dr Nigel Francis. Here, we ask Nigel about his work and his ideas for teaching during the COVID-19 pandemic.
We’re pleased to announce the winner of our 2020 Immunology Teaching Excellence Award is Dr Nigel Francis from Swansea University Medical School.
The International Veterinary Immunology Symposium will take place in the Kruger National Park, South Africa, from 8-12 August 2022. The symposium is held every three years in association with the International Congress of Immunology and brings Industry, Government, and Academic specialists together to provide an update and overview of new, cutting-edge information in basic and applied veterinary immunology.
British Society for Immunology response to phase 2/3 results from the AstraZeneca/University of Oxford trial for theChAdOx1 nCoV-19 vaccine against COVID-19
The role
Edinburgh Napier University are seeking a motivated Postdoctoral Research Fellow to work on a project funded by The Chief Scientists Office (Scotland) focused on developing adoptive T cell therapies for the treatment of rheumatoid arthritis. The project aims to establish the translational protocols to move exciting pre-clinical work toward the clinic, this includes optimising therapeutic cell populations, establishing good-manufacturing practice compliant culture/modification protocols and validating/categorising disease targeting reagents.
Job Description: